Stock Report

All about this stock under one free report Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Harmony Biosciences Holdings (HRMY) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$42.06

up-down-arrow $0.20 (0.48%)

As on 04-Sep-2026 13:35EDT

Market cap

info icon

$2,283 Mln

Revenue (TTM)

info icon

$960 Mln

P/E Ratio

info icon

12.7

P/B Ratio

info icon

2.3

Div. Yield

info icon

0 %

Edit peer-selector-edit
Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Market cap ($ Mln)
 2,283 14,975 12,310 11,972 10,425
Revenue ($ Mln)
 960 692 831 5,020 777
Net Profit ($ Mln)
 181.27 -696.24 54.90 -199.00 -191.64
Net Margin (%)
 18.88 -100.64 6.61 -3.96 -24.68
RoE (%)
 19.39 -- 8.11 -3.03 -223.36
Price to Earnings
 12.69 -- 264.84 -- --
Price-To-Book
 2.32 123.68 17.91 1.79 129.60

Income Statement ($ Mln)

Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Operating Revenue arrow
959.90 691.84 830.81 5,020.00 776.57
Cost of Revenue arrow
235.91 47.45 14.09 2,380.00 52.53
Gross Profit arrow
670.11 473.81 748.43 2,050.00 591.02
Operating Expenses arrow
493.34 1,187.86 810.32 2,178.00 912.58
Operating Profit (EBIT) arrow
230.65 -543.47 6.41 462.00 -188.54
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
241.20 -706.17 26.37 -166.00 -191.09
Provision for Tax arrow
59.93 -7.73 -35.26 33.00 0.56
Profit after Tax (Net Income) arrow
181.27 -696.24 54.90 -199.00 -191.64
Minority Interest arrow
0.00 6.48 0.00 0.00 0.00
Consolidated Profit arrow
0.00 0.00 0.00 0.00 0.00

Liabilities ($ Mln)

Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Shareholder's Funds arrow
999.24 -2,515.22 705.78 6,588.00 83.30
Minority Interest arrow
0.00 6.48 0.00 0.00 0.00
Non-Current Liabilities arrow
139.77 2,832.54 29.12 5,121.00 217.70
Current Liabilities arrow
234.07 890.65 153.80 1,852.00 460.45
Total Liabilities arrow
1,271.63 936.03 836.65 13,358.00 689.81

Assets ($ Mln)

Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Non-Current Assets arrow
558.75 124.16 449.03 9,764.00 104.88
Current Assets arrow
814.33 1,093.14 439.68 3,797.00 656.57
Total Assets arrow
1,271.63 936.03 836.65 13,358.00 689.81
Total Debt* arrow
153.96 2,493.78 9.42 3,918.00 219.21
Net Current Assets arrow
580.26 0.00 285.87 1,945.00 0.00

Cashflow ($ Mln)

Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Cash From Operating Activities arrow
348.20 -445.91 142.00 560.00 -93.41
Cash Flow from Investing Activities arrow
-39.65 -24.49 69.76 -279.00 -0.48
Cash from Financing Activities arrow
-9.05 359.29 -220.37 -275.00 101.47
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
ROCE (%) arrow
16.27 -159.44 14.87 -2.21 -63.21
ROE (%) arrow
19.39 41.15 8.11 -3.03 -223.36
ROA (%) arrow
12.52 -39.04 5.52 -1.30 -15.97
EBIT Margin (%) arrow
26.15 -89.09 3.17 1.61 -17.57
Net Margin (%) arrow
18.88 -100.64 6.61 -3.96 -24.68
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Revenue Growth (%) arrow
24.25 193.38 16.02 11.95 56.87
EBIT Growth (%) arrow
4.09 5.05 -79.11 -90.61 42.45
Net Profit Growth (%) arrow
0.20 10.33 -58.66 -145.85 22.38
EPS Growth (%) arrow
-0.54 12.58 -62.44 -146.42 25.75
Book Value Growth (%) arrow
28.50 -36.90 12.98 -3.87 9.44

Valuation Ratios

 Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Price / Earnings arrow
13.84 -20.69 41.86 -48.47 -50.48
Price / Book Value arrow
2.52 -7.27 6.44 1.72 104.73
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
6.51 -25.60 55.67 21.77 -54.53
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Debt to Equity arrow
0.13 0.00 0.00 0.58 0.00
Short term debt to equity ratio arrow
0.02 -0.22 0.00 0.01 0.85
Current Ratio arrow
3.48 1.23 2.86 2.05 1.43
Quick Ratio arrow
3.45 1.17 2.77 1.10 1.34
Interest Coverage arrow
18.89 -6.86 -- 0.36 -37.09

Operating Efficiency Ratios

 Harmony Biosciences Holdings (HRMY) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Debtors to sales (%) arrow
11.56 36.78 9.26 22.95 35.73
Asset Turnover arrow
0.66 0.39 0.84 0.33 0.65
Receivable days arrow
37.81 52.44 28.27 70.73 104.82
Inventory Days arrow
11.56 172.81 355.76 226.89 167.98
Payable days arrow
28.95 296.14 785.55 45.50 529.03
Cash Conversion Cycle arrow
20.43 -70.89 -401.52 252.12 -256.23
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...